Antibody-drug conjugate (ADC) company, Mersana Therapeutics and Adimab have initiated a joint effort to offer integrated antibody discovery and ADC technologies. The partnership will provide pharmaceutical companies an access to Adimab's ...
Tags: Adimab, Mersana, integrated antibody discovery, ADC technologies
KineMed has entered into a multi-year R&D collaboration GlaxoSmithKline (GSK) to develop kinetic biomarkers. The collaboration will apply KineMed's biomarker discovery platform in therapeutic areas of interest to GSK. KineMed president ...
Tags: kinetic biomarkers, GlaxoSmithKline, KineMed's technology
Clinical stage drug development company Telik has reported a net loss of $1.88m, or $0.78 per share, for the third quarter ended 30 September 2012 compared to a net loss of $2.85m, or $1.58 per share, for the third quarter ended 30 ...
Tags: Clinical stage drug development, net loss, loss from operations
Clinical research organization PRA has opened a second office in China to house its continued expansion in China and the Asia Pacific region. The new Beijing facility is expected to enhance PRA local project teams' ability in meeting the ...
Tags: Clinical research, clinical drug development, clinical sites
TI Pharma, Merck KGaA, Astellas Pharma and the Swiss Tropical and Public Health Institute (Swiss TPH) have entered into an international public-private partnership (PPP) to develop new pediatric formulation of praziquantel for the treatment ...
Tags: Pediatric Formulation, Swiss TPH, treatment of schistosomiasis
Shire and Boston Children's Hospital have formed a three-year, broad research collaboration to develop new therapies to treat rare pediatric diseases. As part of the agreement, Shire will make an initial upfront payment to Boston ...
Tags: pediatric diseases, Children's Hospital, new therapies
NanoViricides, a development stage company, has reported effectiveness of an anti-influenza drug candidate, under FluCide program, when given orally. According to the information received from the contract laboratory that performed the ...
SK Biopharmaceuticals, a South Korean pharmaceutical company, has received orphan drug designation status for carisbamate for the management of patients with infantile spasms (IS). Carisbamate has previously been shown to have ...